Chemours shares sank 32% Thursday, a record drop for the stock, and its plunge triggered trading halts for volatility as Wall Street soured on the titanium dioxide maker. Analysts cautioned that the most recent delay and the placement of its executives on administrative leave is a sign of more serious accounting problems than previously disclosed.
Chief Executive Officer
Learn more about Bloomberg Tax or Log In to keep reading:
Learn About Bloomberg Tax
From research to software to news, find what you need to stay ahead.
Already a subscriber?
Log in to keep reading or access research tools.